[1] Listl S, Jansen L, Stenzinger A, Freier K, Emrich K, Holleczek B, et al. Survival of patients with oral cavity cancer in Germany. PLoS One. 2013;8:e53415.
[2] Taghavi N, Yazdi I. Prognostic factors of survival rate in oral squamous cell carcinoma: clinical, histologic, genetic and molecular concepts. Archives of Iranian medicine. 2015;18:314-9.
[3] Chow LQM. Head and Neck Cancer. The New England journal of medicine. 2020;382:60-72.
[4] Graham K, Unger E. Overcoming tumor hypoxia as a barrier to radiotherapy, chemotherapy and immunotherapy in cancer treatment. International journal of nanomedicine. 2018;13:6049-58.
[5] Masoud GN, Li W. HIF-1α pathway: role, regulation and intervention for cancer therapy. Acta pharmaceutica Sinica B. 2015;5:378-89.
[6] Henze AT, Mazzone M. The impact of hypoxia on tumor-associated macrophages. The Journal of clinical investigation. 2016;126:3672-9.
[7] Wu CS, Chang IY, Hung JL, Liao WC, Lai YR, Chang KP, et al. ASC modulates HIF-1α stability and induces cell mobility in OSCC. Cell death & disease. 2020;11:721.
[8] Datta NR, Rogers S, Ordóñez SG, Puric E, Bodis S. Hyperthermia and radiotherapy in the management of head and neck cancers: A systematic review and meta-analysis. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 2016;32:31-40.
[9] Lepock JR. Role of nuclear protein denaturation and aggregation in thermal radiosensitization. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 2004;20:115-30.
[10] Krenacs T, Meggyeshazi N, Forika G, Kiss E, Hamar P, Szekely T, et al. Modulated Electro-Hyperthermia-Induced Tumor Damage Mechanisms Revealed in Cancer Models. International journal of molecular sciences. 2020;21.
[11] Thanou M, Gedroyc W. MRI-Guided Focused Ultrasound as a New Method of Drug Delivery. Journal of drug delivery. 2013;2013:616197.
[12] Chiang CF, Hsu YH, Liu CC, Liang PC, Miaw SC, Lin WL. Pulsed-wave Ultrasound Hyperthermia Enhanced Nanodrug Delivery Combined with Chloroquine Exerts Effective Antitumor Response and Postpones Recurrence. Scientific reports. 2019;9:12448.
[13] Zhang Y, Calderwood SK. Autophagy, protein aggregation and hyperthermia: a mini-review. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 2011;27:409-14.
[14] Ahmed K, Zaidi SF, Mati Ur R, Rehman R, Kondo T. Hyperthermia and protein homeostasis: Cytoprotection and cell death. Journal of thermal biology. 2020;91:102615.
[15] Nivon M, Richet E, Codogno P, Arrigo AP, Kretz-Remy C. Autophagy activation by NFkappaB is essential for cell survival after heat shock. Autophagy. 2009;5:766-83.
[16] Chen T, Cen D, Ren Z, Wang Y, Cai X, Huang J, et al. Bismuth embedded silica nanoparticles loaded with autophagy suppressant to promote photothermal therapy. Biomaterials. 2019;221:119419.
[17] Laha D, Deb M, Das H. KLF2 (kruppel-like factor 2 [lung]) regulates osteoclastogenesis by modulating autophagy. Autophagy. 2019;15:2063-75.
[18] Kasprowska-Liśkiewicz D. The cell on the edge of life and death: Crosstalk between autophagy and apoptosis. Postepy higieny i medycyny doswiadczalnej (Online). 2017;71:825-41.
[19] Hwang JY, Gertner M, Pontarelli F, Court-Vazquez B, Bennett MV, Ofengeim D, et al. Global ischemia induces lysosomal-mediated degradation of mTOR and activation of autophagy in hippocampal neurons destined to die. Cell death and differentiation. 2017;24:317-29.
[20] Qu L, Chen C, Chen Y, Li Y, Tang F, Huang H, et al. High-Mobility Group Box 1 (HMGB1) and Autophagy in Acute Lung Injury (ALI): A Review. Medical science monitor : international medical journal of experimental and clinical research. 2019;25:1828-37.
[21] Raucci A, Di Maggio S, Scavello F, D'Ambrosio A, Bianchi ME, Capogrossi MC. The Janus face of HMGB1 in heart disease: a necessary update. Cellular and molecular life sciences : CMLS. 2019;76:211-29.
[22] Kang R, Chen R, Zhang Q, Hou W, Wu S, Cao L, et al. HMGB1 in health and disease. Molecular aspects of medicine. 2014;40:1-116.
[23] Katabi N, Lewis JS. Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: What Is New in the 2017 WHO Blue Book for Tumors and Tumor-Like Lesions of the Neck and Lymph Nodes. Head and neck pathology. 2017;11:48-54.
[24] Monden N, Asakage T, Kiyota N, Homma A, Matsuura K, Hanai N, et al. A review of head and neck cancer staging system in the TNM classification of malignant tumors (eighth edition). Japanese journal of clinical oncology. 2019;49:589-95.
[25] Rouschop KM, Wouters BG. Regulation of autophagy through multiple independent hypoxic signaling pathways. Current molecular medicine. 2009;9:417-24.
[26] Liu EY, Ryan KM. Autophagy and cancer--issues we need to digest. Journal of cell science. 2012;125:2349-58.
[27] Powis G, Kirkpatrick L. Hypoxia inducible factor-1alpha as a cancer drug target. Molecular cancer therapeutics. 2004;3:647-54.
[28] Gordan JD, Thompson CB, Simon MC. HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation. Cancer cell. 2007;12:108-13.
[29] Dang CV, Le A, Gao P. MYC-induced cancer cell energy metabolism and therapeutic opportunities. Clinical cancer research : an official journal of the American Association for Cancer Research. 2009;15:6479-83.
[30] Nakashima R, Goto Y, Koyasu S, Kobayashi M, Morinibu A, Yoshimura M, et al. UCHL1-HIF-1 axis-mediated antioxidant property of cancer cells as a therapeutic target for radiosensitization. Scientific reports. 2017;7:6879.
[31] Lee GY, Chun YS, Shin HW, Park JW. Potential role of the N-MYC downstream-regulated gene family in reprogramming cancer metabolism under hypoxia. Oncotarget. 2016;7:57442-51.
[32] Yoshida GJ. Metabolic reprogramming: the emerging concept and associated therapeutic strategies. Journal of experimental & clinical cancer research : CR. 2015;34:111.
[33] Rabinowitz JD, White E. Autophagy and metabolism. Science (New York, NY). 2010;330:1344-8.
[34] Li YY, Feun LG, Thongkum A, Tu CH, Chen SM, Wangpaichitr M, et al. Autophagic Mechanism in Anti-Cancer Immunity: Its Pros and Cons for Cancer Therapy. International journal of molecular sciences. 2017;18.
[35] Ribeiro M, Teixeira SR, Azevedo MN, Fraga AC, Jr., Gontijo AP, Vêncio EF. Expression of hypoxia-induced factor-1 alpha in early-stage and in metastatic oral squamous cell carcinoma. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 2017;39:1010428317695527.
[36] Marrero JA, Kudo M, Bronowicki JP. The challenge of prognosis and staging for hepatocellular carcinoma. The oncologist. 2010;15 Suppl 4:23-33.
[37] Venereau E, Casalgrandi M, Schiraldi M, Antoine DJ, Cattaneo A, De Marchis F, et al. Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release. The Journal of experimental medicine. 2012;209:1519-28.
[38] Yu L, Chen Y, Tooze SA. Autophagy pathway: Cellular and molecular mechanisms. Autophagy. 2018;14:207-15.
[39] Xilouri M, Brekk OR, Polissidis A, Chrysanthou-Piterou M, Kloukina I, Stefanis L. Impairment of chaperone-mediated autophagy induces dopaminergic neurodegeneration in rats. Autophagy. 2016;12:2230-47.
[40] Priolo C, Pyne S, Rose J, Regan ER, Zadra G, Photopoulos C, et al. AKT1 and MYC induce distinctive metabolic fingerprints in human prostate cancer. Cancer research. 2014;74:7198-204.
[41] Jones NP, Schulze A. Targeting cancer metabolism--aiming at a tumour's sweet-spot. Drug discovery today. 2012;17:232-41.
[42] Mizushima N, Yoshimori T, Levine B. Methods in mammalian autophagy research. Cell. 2010;140:313-26.
[43] Schiraldi M, Raucci A, Muñoz LM, Livoti E, Celona B, Venereau E, et al. HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4. The Journal of experimental medicine. 2012;209:551-63.
[44] Jiang J, Chen S, Li K, Zhang C, Tan Y, Deng Q, et al. Targeting autophagy enhances heat stress-induced apoptosis via the ATP-AMPK-mTOR axis for hepatocellular carcinoma. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 2019;36:499-510.
[45] Wu X, Wu Y, Wang Z, Liu L, Sun C, Chen Y, et al. A Cascade-Targeting Nanocapsule for Enhanced Photothermal Tumor Therapy with Aid of Autophagy Inhibition. Advanced healthcare materials. 2018;7:e1800121.
[46] Wan HY, Chen JL, Zhu X, Liu L, Wang J, Zhu XM. Titania-Coated Gold Nano-Bipyramids for Blocking Autophagy Flux and Sensitizing Cancer Cells to Proteasome Inhibitor-Induced Death. Advanced science (Weinheim, Baden-Wurttemberg, Germany). 2018;5:1700585.
[47] Yang Y, Yang CL, Zhao ZJ, Zuo XX, Liang TS, Yang Y, et al. Microwave hyperthermia enhances the sensitivity of lung cancer cells to gemcitabine through reactive oxygen species‑induced autophagic death. Oncology reports. 2019;41:3100-10.
[48] Ba MC, Long H, Cui SZ, Gong YF, Yan ZF, Wang S, et al. Mild hyperthermia enhances sensitivity of gastric cancer cells to chemotherapy through reactive oxygen species-induced autophagic death. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 2017;39:1010428317711952.
[49] Wu Y, Pan M, Cui S, Ba M, Chen Z, Ruan Q. Autophagic death induced by thermo‑chemotherapy in gastric cancer cells results from the reactive oxygen species pathway. Molecular medicine reports. 2016;14:1210-8.
[50] Agani F, Jiang BH. Oxygen-independent regulation of HIF-1: novel involvement of PI3K/AKT/mTOR pathway in cancer. Current cancer drug targets. 2013;13:245-51.
[51] Belaiba RS, Bonello S, Zähringer C, Schmidt S, Hess J, Kietzmann T, et al. Hypoxia up-regulates hypoxia-inducible factor-1alpha transcription by involving phosphatidylinositol 3-kinase and nuclear factor kappaB in pulmonary artery smooth muscle cells. Molecular biology of the cell. 2007;18:4691-7.
[52] Wan J, Wu W. Hyperthermia induced HIF-1a expression of lung cancer through AKT and ERK signaling pathways. Journal of experimental & clinical cancer research : CR. 2016;35:119.
[53] Lee Titsworth W, Murad GJ, Hoh BL, Rahman M. Fighting fire with fire: the revival of thermotherapy for gliomas. Anticancer research. 2014;34:565-74.
[54] Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 2002;418:191-5.
[55] Bell CW, Jiang W, Reich CF, 3rd, Pisetsky DS. The extracellular release of HMGB1 during apoptotic cell death. American journal of physiology Cell physiology. 2006;291:C1318-25.
[56] Kang R, Zhang Q, Zeh HJ, 3rd, Lotze MT, Tang D. HMGB1 in cancer: good, bad, or both? Clinical cancer research : an official journal of the American Association for Cancer Research. 2013;19:4046-57.
[57] Dupont N, Jiang S, Pilli M, Ornatowski W, Bhattacharya D, Deretic V. Autophagy-based unconventional secretory pathway for extracellular delivery of IL-1β. The EMBO journal. 2011;30:4701-11.
[58] Luo Y, Yoneda J, Ohmori H, Sasaki T, Shimbo K, Eto S, et al. Cancer usurps skeletal muscle as an energy repository. Cancer research. 2014;74:330-40.
[59] Lin YS, Shen YJ, Ou PH, Lai CJ. HIF-1α-Mediated, NADPH Oxidase-Derived ROS Contributes to Laryngeal Airway Hyperreactivity Induced by Intermittent Hypoxia in Rats. Frontiers in physiology. 2020;11:575260.
[60] Bao Y, Ding Z, Zhao P, Li J, Chen P, Zheng J, et al. Autophagy inhibition potentiates the anti-EMT effects of alteronol through TGF-β/Smad3 signaling in melanoma cells. Cell death & disease. 2020;11:223.
[61] Wang K. Autophagy and apoptosis in liver injury. Cell cycle (Georgetown, Tex). 2015;14:1631-42.
[62] Liang J, Shao SH, Xu ZX, Hennessy B, Ding Z, Larrea M, et al. The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis. Nature cell biology. 2007;9:218-24.
[63] Nikoletopoulou V, Markaki M, Palikaras K, Tavernarakis N. Crosstalk between apoptosis, necrosis and autophagy. Biochimica et biophysica acta. 2013;1833:3448-59.